Lona Poole

2.9k total citations
13 papers, 1.4k citations indexed

About

Lona Poole is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Lona Poole has authored 13 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Lona Poole's work include Erythropoietin and Anemia Treatment (5 papers), Sepsis Diagnosis and Treatment (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Lona Poole is often cited by papers focused on Erythropoietin and Anemia Treatment (5 papers), Sepsis Diagnosis and Treatment (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Lona Poole collaborates with scholars based in United States, Japan and Russia. Lona Poole's co-authors include Richard G. Wunderink, Edward Abraham, Gerry S. San Pedro, Steve Berman, R. Bruce Light, Steven B. Porter, Mark J. Rumbak, Antonio Anzueto, Robert N. Cooney and James E. Pennington and has published in prestigious journals such as The Lancet, CHEST Journal and Journal of the American Society of Nephrology.

In The Last Decade

Lona Poole

12 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lona Poole United States 7 496 428 358 237 207 13 1.4k
Randy Allred United States 9 509 1.0× 525 1.2× 449 1.3× 47 0.2× 392 1.9× 11 1.6k
Mark Roest Netherlands 25 170 0.3× 555 1.3× 180 0.5× 66 0.3× 240 1.2× 65 1.9k
Yasunori Abe Japan 19 312 0.6× 430 1.0× 449 1.3× 36 0.2× 229 1.1× 50 1.7k
Alexander Lukasz Germany 19 373 0.8× 80 0.2× 165 0.5× 316 1.3× 340 1.6× 38 1.4k
Nikitas Nikitas Greece 17 241 0.5× 232 0.5× 91 0.3× 49 0.2× 300 1.4× 42 865
F. Schindel Germany 10 717 1.4× 379 0.9× 158 0.4× 72 0.3× 98 0.5× 13 1.2k
José Hermida Spain 22 91 0.2× 518 1.2× 180 0.5× 31 0.1× 251 1.2× 60 1.3k
Maik Soßdorf Germany 11 371 0.7× 117 0.3× 414 1.2× 82 0.3× 144 0.7× 22 922
Suzanne Fateh‐Moghadam Germany 19 455 0.9× 380 0.9× 252 0.7× 20 0.1× 134 0.6× 36 1.6k
Danyelle Romana Alves Rios Brazil 18 83 0.2× 243 0.6× 142 0.4× 126 0.5× 125 0.6× 68 1.1k

Countries citing papers authored by Lona Poole

Since Specialization
Citations

This map shows the geographic impact of Lona Poole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lona Poole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lona Poole more than expected).

Fields of papers citing papers by Lona Poole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lona Poole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lona Poole. The network helps show where Lona Poole may publish in the future.

Co-authorship network of co-authors of Lona Poole

This figure shows the co-authorship network connecting the top 25 collaborators of Lona Poole. A scholar is included among the top collaborators of Lona Poole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lona Poole. Lona Poole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kim, Grace Hyun J., Xueping Zhang, Matthew S. Brown, Lona Poole, & Jonathan Goldin. (2025). Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II trials of pamrevlumab. BMJ Open. 15(5). e094559–e094559. 1 indexed citations
2.
Raghu, Ganesh, Luca Richeldi, Evans R. Fernández Pérez, et al.. (2024). Pamrevlumab for Idiopathic Pulmonary Fibrosis: Results of the Phase 3 Zephyrus-1 Study. A6613–A6613. 1 indexed citations
3.
4.
Provenzano, Robert, Evgeny Shutov, Lona Poole, et al.. (2021). Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. Nephrology Dialysis Transplantation. 36(9). 1717–1730. 85 indexed citations
5.
Fishbane, Steven, Robert Provenzano, Anjay Rastogi, et al.. (2020). Roxadustat Lowers Risk of Red Blood Cell Transfusion in Patients with Anemia of CKD. Journal of the American Society of Nephrology. 31(10S). 130–130. 2 indexed citations
6.
Provenzano, Robert, Kumar Jayant, Steven Fishbane, et al.. (2020). Subgroup Analyses of Efficacy of Roxadustat for Treatment of Anemia in Patients with Incident Dialysis-Dependent CKD. Journal of the American Society of Nephrology. 31(10S). 131–131. 2 indexed citations
7.
8.
Besarab, Anatole, Е. А. Chernyavskaya, Evgeny Shutov, et al.. (2015). Roxadustat (FG-4592). Journal of the American Society of Nephrology. 27(4). 1225–1233. 210 indexed citations
9.
Pierce, David M., Stuart Hossack, Lona Poole, et al.. (2010). The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol. Nephrology Dialysis Transplantation. 26(5). 1615–1621. 29 indexed citations
10.
Laterre, Pierre-François, Steven M. Opal, Edward Abraham, et al.. (2009). A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia. Critical Care. 13(2). R36–R36. 35 indexed citations
11.
Wunderink, Richard G., Lona Poole, Fang Xie, Pierre‐François Laterre, & Steven M. Opal. (2005). COAGULATION STATUS AND RESPONSE TO TIFACOGIN IN COMMUNITY-ACQUIRED PNEUMONIA. CHEST Journal. 128(4). 151S–151S. 2 indexed citations
12.
Abraham, Edward, Antonio Anzueto, Guillermo Gutiérrez, et al.. (1998). Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. The Lancet. 351(9107). 929–933. 369 indexed citations
13.
Abraham, Edward, Antonio Anzueto, Guillermo Gutiérrez, et al.. (1998). Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.. PubMed. 351(9107). 929–33. 490 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randy Allred Breakdown of academic impact, for papers by Mark Roest Breakdown of academic impact, for papers by Yasunori Abe Breakdown of academic impact, for papers by Alexander Lukasz Breakdown of academic impact, for papers by Nikitas Nikitas Breakdown of academic impact, for papers by F. Schindel Breakdown of academic impact, for papers by José Hermida Breakdown of academic impact, for papers by Maik Soßdorf Breakdown of academic impact, for papers by Suzanne Fateh‐Moghadam Breakdown of academic impact, for papers by Danyelle Romana Alves Rios
Rankless by CCL
2026